Cara Therapeutics (CARA) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CARA Hot Sheet
Join SI Premium – FREE
Cara Therapeutics (NASDAQ: CARA) reported Q2 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Cara Therapeutics (CARA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- Nebius Group closes $5.75B convertible notes offering
- US Tiger Securities Reiterates Hold Rating on Pinduoduo Inc. (PDD)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
